Pfizer stock: BofA raises target for Pfizer stock to USD 29.00

Published on 10/21/2026 at 16:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue hit USD 15.03 billion, up 1.00 percent. Pfizer stock costs EUR 26.67 on October 21, 2026, down 0.52 percent versus the Xetra close.

Analyst target and earnings

On October 9, 2026, BofA moved its Pfizer target from USD 27.00 to USD 29.00.
Second-quarter 2026 revenue reached USD 15.03 billion, up 1.00 percent operationally year over year.
Pfizer stock costs EUR 26.67 at Lang & Schwarz on October 21, 2026 at 4:41 p.m. CEST, 0.52 percent below the Xetra close.
Pfizer's next webcast is scheduled for November 3, 2026.

Editorialfoto eines Trading-Floors mit Sektor-Charts, Symbolbild für den Aktienhandel von Pfizer Inc — Börsen-Editorialfoto vom Trading-Floor mit Pharma-Charts steht sinnbildlich für den Aktienhandel von Pfizer Inc., ISIN US7170811035, Illustration mit AI erstellt.

Pfizer Inc. (ISIN US7170811035) drew a higher valuation from Bank of America on October 9, 2026, when analyst Jason Gerberry lifted the price target from USD 27.00 to USD 29.00 while keeping a Neutral rating, as Markets Insider reported. The target lies 2.85 percent below Pfizer's USD 29.85 NYSE price at 10:54 a.m. ET on October 21, 2026. At Lang & Schwarz, Pfizer stock was trading at EUR 26.67 on October 21, 2026 at 4:41 p.m. CEST, down 0.52 percent versus the Xetra close of October 20, 2026 at EUR 26.81.

Second-quarter revenue reached USD 15.03 billion

Pfizer's second-quarter 2026 revenue reached USD 15.03 billion, an operational increase of 1.00 percent from the prior-year quarter. Adjusted diluted earnings per share came in at USD 0.77, while GAAP diluted earnings per share were negative USD 0.04. The figures were discussed in Pfizer's second-quarter earnings call transcript published by Yahoo Finance on August 4, 2026.

Pfizer stock stays near its yearly high

The USD 29.85 NYSE price was 1.32 percent below Pfizer's 52-week high of USD 30.25 and 26.36 percent above its 52-week low of USD 23.62 on October 21, 2026. The current market capitalization was USD 170.1 billion, and the price-to-earnings ratio was 39.42. Pfizer's trading volume stood at 4,670,117 shares at 10:54 a.m. ET.

When is Pfizer's next update?

Pfizer's website lists a webcast for November 3, 2026, giving investors a dated point for the next company communication. The current dividend yield was 6.00 percent on October 21, 2026, while the analyst target from BofA remains below the NYSE price.

Price and investor perspective

The analyst revision adds a fresh valuation marker, but the USD 29.00 target remains below the USD 29.85 NYSE price. The second-quarter figures combine 1.00 percent operational revenue growth with adjusted diluted earnings per share of USD 0.77.

Pfizer stock was trading at EUR 26.67 at Lang & Schwarz on October 21, 2026 at 4:41 p.m. CEST, down 0.52 percent versus the Xetra close of October 20, 2026 at EUR 26.81. The further course of trading is shown by the continuously updated real-time quote of Pfizer stock.